C3, a key protein in the complement system, had allotypes related to the susceptibility to CD and the development of cardiomyopathy (Messias-Reason et al., 2003), suggesting that PTX might act in the complement signaling pathway and reversion of C3 expression might slow down CCC progression, a matter to be further investigated. Here, C3 is linked to cardiomyopathy.